US10610166B2 - Determination of a hemodynamic parameter - Google Patents
Determination of a hemodynamic parameter Download PDFInfo
- Publication number
- US10610166B2 US10610166B2 US14/770,409 US201414770409A US10610166B2 US 10610166 B2 US10610166 B2 US 10610166B2 US 201414770409 A US201414770409 A US 201414770409A US 10610166 B2 US10610166 B2 US 10610166B2
- Authority
- US
- United States
- Prior art keywords
- standard deviation
- data
- hemodynamic parameter
- polynomial function
- determining
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active, expires
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7271—Specific aspects of physiological measurement analysis
- A61B5/7278—Artificial waveform generation or derivation, e.g. synthesizing signals from measured signals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B5/0205—Simultaneously evaluating both cardiovascular conditions and different types of body conditions, e.g. heart and respiratory condition
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B5/021—Measuring pressure in heart or blood vessels
- A61B5/02108—Measuring pressure in heart or blood vessels from analysis of pulse wave characteristics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B5/021—Measuring pressure in heart or blood vessels
- A61B5/0215—Measuring pressure in heart or blood vessels by means inserted into the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B5/024—Measuring pulse rate or heart rate
- A61B5/02416—Measuring pulse rate or heart rate using photoplethysmograph signals, e.g. generated by infrared radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B5/026—Measuring blood flow
- A61B5/0261—Measuring blood flow using optical means, e.g. infrared light
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B5/026—Measuring blood flow
- A61B5/029—Measuring blood output from the heart, e.g. minute volume
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B5/026—Measuring blood flow
- A61B5/0295—Measuring blood flow using plethysmography, i.e. measuring the variations in the volume of a body part as modified by the circulation of blood therethrough, e.g. impedance plethysmography
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7203—Signal processing specially adapted for physiological signals or for diagnostic purposes for noise prevention, reduction or removal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7203—Signal processing specially adapted for physiological signals or for diagnostic purposes for noise prevention, reduction or removal
- A61B5/7217—Signal processing specially adapted for physiological signals or for diagnostic purposes for noise prevention, reduction or removal of noise originating from a therapeutic or surgical apparatus, e.g. from a pacemaker
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7271—Specific aspects of physiological measurement analysis
- A61B5/7275—Determining trends in physiological measurement data; Predicting development of a medical condition based on physiological measurements, e.g. determining a risk factor
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
Definitions
- This disclosure is related to the field of patient hemodynamic monitoring and digital signal processing. This disclosure specifically relates to a method of calculating real-time hemodynamic parameters.
- Indicators such as stroke volume (SV), cardiac output (CO), end-diastolic volume, ejection fraction, stroke volume variation (SVV), pulse pressure variation (PPV), systolic pressure variations (SPV), and plethysmographic variability index (PVI), among others, are important not only for diagnosis of disease, but also for “real-time” monitoring of preload dependence, fluid responsiveness, or volume responsiveness condition of both human and animal subjects. Few hospitals are therefore without some form of equipment to monitor one or more of these cardiac parameters. Many techniques, including invasive techniques, non-invasive techniques, and combinations thereof, are in use and even more have been proposed in the literature. References that disclose determination of hemodynamic parameters include WO02011094487 (Jian et al., filed 28 Jan. 2011) and WO 2009023713 (Derderian et al., filed 13 Aug. 2008).
- One way to obtain a hemodynamic parameter is to mount a flow-measuring device on a catheter, and position the device in or near the subject's heart.
- Some such devices inject either a bolus of material or energy (usually heat) at an upstream position, such as in the right atrium, and determine flow based on the characteristics of the injected material or energy at a downstream position, such as in the pulmonary artery.
- Patents that disclose implementations of such invasive techniques include: U.S. Pat. No. 4,236,527 (Newbower et al., 2 Dec. 1980); U.S. Pat. No. 4,507,974 (Yelderman, 2 Apr. 1985); U.S. Pat. No.
- PCM pulse contour method
- the three required parameters of the model are usually determined either empirically, through a complex calibration process, or from compiled “anthropometric” data, i.e., data about the age, sex, height, weight, and/or other parameters of other patients or test subjects.
- U.S. Pat. No. 5,400,793 (Wesseling, 28 Mar. 1995) and U.S. Pat. No. 5,535,753 (Petrucelli et al., 16 Jul. 1996) disclose systems that rely on a Windkessel circuit model to determine a hemodynamic parameter.
- PCM-based systems can monitor hemodynamic parameters using blood pressure measurements taken using a variety of measurement apparatus, such as a finger cuff, and can do so more or less continuously.
- Many improvements, with varying degrees of complexity, have been proposed for improving the accuracy of the basic PCM model.
- the present disclosure offers an improvement over the PCM model or any other models discussed in this section.
- a method for determining a hemodynamic parameter comprises: receiving data associated with at least one heart beat; calculating a first standard deviation for at least a portion of the data; interpolating a second standard deviation for at least a second portion of the data; and determining, using a computing device processor, the hemodynamic parameter based on the first standard deviation and the second standard deviation.
- the hemodynamic parameter comprises a stroke volume variation (SVV)
- the data comprises blood pressure data
- the hemodynamic parameter comprises a pulse pressure variation (PPV)
- the data comprises pulse pressure data
- the hemodynamic parameter comprises a systolic pressure variation (SPV)
- the data comprises systolic pressure data
- the hemodynamic parameter comprises a plethysmographic variability index (PVI)
- the data comprises pulse oximeter waveform data.
- PVI plethysmographic variability index
- the method further comprises determining, using a computing device processor, a polynomial function that fits the first standard deviation, the polynomial function being associated with at least one polynomial coefficient.
- the polynomial function is based on a least-squares function.
- receiving data comprises measuring at least one arterial blood pressure waveform and identifying the at least one heart beat.
- the method further comprises subtracting the second standard deviation from the first standard deviation.
- determining the hemodynamic parameter further comprises determining the hemodynamic parameter based on a constant, a standard deviation of the second standard deviation, and a mean of the first standard deviation.
- determining the hemodynamic parameter further comprises determining the hemodynamic parameter based on multiplying the constant and the standard deviation of the second standard deviation to produce a first computation, and dividing the first computation by the mean of the first standard deviation.
- the polynomial function is a first order polynomial function.
- the polynomial function is an n th order polynomial function.
- an apparatus for determining a hemodynamic parameter.
- the apparatus comprises a communication interface; a memory; a processor; and a module stored in the memory, executable by the processor, and configured to: receive data associated with at least one heart beat; calculate a first standard deviation for at least a portion of the data; interpolate a second standard deviation for at least a second portion of the data; and determine the hemodynamic parameter based on the first standard deviation and the second standard deviation.
- the apparatus further comprises a kit comprising at least one of a catheter and a pressure sensor associated with the catheter.
- the apparatus further comprises at least one of a signal filter or an analog-to-digital converter.
- a computer program product for determining a hemodynamic parameter.
- the computer program product comprises a non-transitory computer-readable medium comprising a set of codes for causing a computer to: receive data associated with at least one heart beat; calculate a first standard deviation for at least a portion of the data; interpolate a second standard deviation for at least a second portion of the data; and determine the hemodynamic parameter based on the first standard deviation and the second standard deviation.
- an apparatus for determining a hemodynamic parameter.
- the apparatus comprises means for receiving data associated with at least one heart beat; means for calculating a first standard deviation for at least a portion of the data; means for interpolating a second standard deviation for at least a second portion of the data; and means for determining the hemodynamic parameter based on the first standard deviation and the second standard deviation.
- a method for determining a hemodynamic parameter. The method comprises: receiving data associated with at least one heart beat; calculating a first standard deviation for at least a portion of the data; using a Fourier transform and filtering scheme to remove at least a second portion of the data; using an inverse Fourier transform to obtain a second standard deviation for at least a second portion of the data; and determining, using a computing device processor, the hemodynamic parameter based on the first standard deviation and the second standard deviation. Apparatus and computer program product may also be provided based on this method.
- another method for determining a hemodynamic parameter.
- the method comprises: receiving a first portion of data associated with at least one heart beat; interpolating a second portion of the data based on the first portion of the data; calculating at least one standard deviation for at least one of the first portion of the data or the second portion of the data; and determining, using a computing device processor, the hemodynamic parameter based on the at least one standard deviation.
- the hemodynamic parameter comprises at least one of SVV, PPV, SPV, or PVI. Apparatus and computer program product may also be provided based on this method.
- FIG. 1 shows an example of radial artery pressure before a bolus vasopressor of phenylephrine is given to patients
- FIG. 2 shows an example of radial artery pressure after a bolus vasopressor of phenylephrine is given to patients
- FIG. 3 shows an example of a hemodynamic parameter determination method using the pressure obtained before the bolus of phenylephrine is given to a patient
- FIG. 4 shows an example of a hemodynamic parameter determination method using the pressure obtained after the bolus of phenylephrine is given to a patient
- FIG. 5 shows an exemplary method for determining a hemodynamic parameter
- FIG. 6 shows another exemplary method for determining a hemodynamic parameter
- FIG. 7 shows an exemplary apparatus for determining a hemodynamic parameter.
- Embodiments of the disclosure are directed to apparatuses, methods and computer program products for determining or calculating a hemodynamic parameter.
- This disclosure provides a new method to calculate hemodynamic parameters such as stroke volume variation (SVV), pulse pressure variation (PPV), systolic pressure variation (SPV), and plethysmographic variability index (PVI) based on blood pressure waveforms.
- hemodynamic parameters such as stroke volume variation (SVV), pulse pressure variation (PPV), systolic pressure variation (SPV), and plethysmographic variability index (PVI) based on blood pressure waveforms.
- SVV stroke volume variation
- PV pulse pressure variation
- SPV systolic pressure variation
- PVI plethysmographic variability index
- Exemplary methods of the present disclosure are directed to determining SVV. However, these methods or variations of these methods may be used to determine other hemodynamic parameters, including, but not limited to, SPV, PPV, or PVI.
- a method for calculating SVV which is induced by mechanical ventilation, predicts fluid responsiveness with high sensitivity and specificity. As a result, it is often used by clinicians as a guide for fluid optimization.
- This method of calculation or determination of the SVV may be referred to as the first method.
- the first method does reasonably well in predicting fluid responsiveness. The issue of this method, however, is that it does not completely distinguish the variation of stroke volume due to the mechanical ventilation from variation due to other causes. As a result, the first method may not predict fluid responsiveness with high accuracy (e.g., accuracy equal to or greater than a threshold accuracy).
- FIG. 1 shows an example of radial artery pressure before a bolus vasopressor of phenylephrine is given to patients.
- the top plot shows the pressure and the bottom plot shows the standard deviation of blood pressure in each beat.
- the respiration-induced variation of stroke volume can be clearly observed in both plots of FIG. 1 .
- FIG. 2 shows an example of radial artery pressure after a bolus vasopressor of phenylephrine is given to patients.
- the top plot shows the pressure and the bottom plot shows the standard deviation of blood pressure in each beat.
- the respiration-induced variation of stroke volume can be observed, but in addition to that, it comes with a significant change of stroke volume induced by the bolus phenylephrine.
- the present disclosure is directed to a second method to determine a hemodynamic parameter such as SVV.
- This method removes many of the variations of stroke volume due to other sources from the determination, thus improving the sensitivity and specificity of the SVV's or any other hemodynamic parameter's ability in predicting fluid responsiveness.
- FIG. 5 presents an exemplary process flow or method for determining a hemodynamic parameter. This is the second method described previously. The second method is different from the first method primarily due to an interpolation step (see block 530 ).
- the process flow comprises receiving data associated with at least one heart beat. Receiving data associated with at least one heart beat may comprise measuring a waveform and identifying at least one heart beat using a digital signal processing algorithm. In some embodiments, receiving data comprises measuring at least one arterial blood pressure waveform and identifying at least one heart beat. As indicated previously, the data may comprise a blood pressure waveform.
- the blood pressure waveform corresponds to a signal, for example, from an arterial blood pressure, or any signal proportional to, or derived from the arterial pressure signal such as a pulse-oximetry signal, a Doppler ultrasound signal or a bioimpedance signal.
- the process flow comprises calculating a first standard deviation for at least a portion (or first portion) of the data.
- the process flow further comprises determining a polynomial function that fits the first standard deviation, wherein the polynomial function (e.g., 1 st order, 2 nd order, n th order, or any combination thereof) is associated with at least one polynomial coefficient.
- the polynomial function may be based on a least-squares function.
- the process flow comprises interpolating a second standard deviation for at least a second portion of the data (different from the first portion of the data). The interpolation may be performed based on the polynomial function. In some embodiments, the process flow further comprises subtracting the second standard deviation from the first standard deviation.
- the process flow comprises determining a hemodynamic parameter (e.g., associated with a non-respiration effect) based on the first standard deviation and the second standard deviation.
- the determining of the hemodynamic parameter is further configured to determine the hemodynamic parameter based on multiplying the constant and the standard deviation of the second standard deviation to produce a first computation, and dividing the first computation by the mean of the first standard deviation. Constant is again an empirically determined or selected scaling constant.
- the operation of determining a polynomial function and the operation depicted at 540 can be replaced with using a Fourier transform and filtering scheme (e.g., high-pass filtering scheme) to remove at least a second portion of the data, and then using an inverse Fourier transform to obtain the second standard deviation for at least a second portion of the data.
- a Fourier transform and filtering scheme e.g., high-pass filtering scheme
- first and second standard deviation are not used to indicate orders of standard deviation; instead, they are used to indicate a first standard deviation calculation and a second standard deviation calculation. Both the first standard deviation calculation and the second standard deviation calculation may be associated with any order of standard deviation.
- the received data (as indicated in block 510 ) of the second method changes depending on the hemodynamic parameter that is to be determined.
- blood pressure data comprising a blood pressure waveform
- the process flow comprises calculating a first standard deviation for at least a portion (or first portion) of the blood pressure data.
- the process flow comprises interpolating a second standard deviation for at least a second portion of the blood pressure data (different from the first portion of the blood pressure data).
- the process flow comprises determining the SVV based on the first standard deviation and the second standard deviation.
- systolic pressure data (comprising a systolic pressure waveform) is received at block 510 .
- the process flow comprises calculating a first standard deviation for at least a portion (or first portion) of the systolic pressure data.
- the process flow comprises interpolating a second standard deviation for at least a second portion of the systolic pressure data (different from the first portion of the systolic pressure data).
- the process flow comprises determining the SPV based on the first standard deviation and the second standard deviation.
- pulse pressure data (comprising a pulse pressure waveform) is received at block 510 .
- the process flow comprises calculating a first standard deviation for at least a portion (or first portion) of the pulse pressure data.
- the process flow comprises interpolating a second standard deviation for at least a second portion of the pulse pressure data (different from the first portion of the pulse pressure data).
- the process flow comprises determining the PPV based on the first standard deviation and the second standard deviation.
- pulse oximeter waveform data (comprising a pulse oximeter waveform) is received at block 510 .
- the process flow comprises calculating a first standard deviation for at least a portion (or first portion) of the pulse oximeter waveform data.
- the process flow comprises interpolating a second standard deviation for at least a second portion of the pulse oximeter waveform data (different from the first portion of the pulse oximeter waveform data).
- the process flow comprises determining the PVI based on the first standard deviation and the second standard deviation.
- FIG. 3 shows an example of the second method using the pressure obtained before a bolus of phenylephrine is given to a patient.
- the SVV obtained with the first method and the second method are quite close, as expected, since in the second method, the variation of the stroke volume is mainly induced by the respiration effect.
- the top plot in FIG. 3 illustrates blood pressure before a bolus phenylephrine is given to a patient.
- each circle e.g., circle 302
- the line 304 shows the fitted first order polynomial.
- Each square e.g., square 306
- Some circles are only partially visible or not visible because they at least partially overlap with some squares.
- the SVV calculated via the first and second methods are very close to each other. They are 17.03% and 17.04%, respectively.
- FIG. 4 shows an example of the second method using the pressure obtained after the bolus of phenylephrine is given to a patient.
- the SVV obtained with the first method and the second method are quite different, as expected, since in the second method, the variation of the stroke volume is induced not only by the respiration effect, but also by other non-respiration induced effect.
- the SVV calculated using the second method removes much of the non-respiration effect and its value is much closer to the true value.
- the top plot in FIG. 4 shows the blood pressure after a bolus phenylephrine is given to a patient.
- each circle e.g., circle 402
- the line 404 shows the fitted first order polynomial.
- the square e.g., square 406
- Some circles are only partially visible or not visible because they at least partially overlap with some squares.
- the SVV calculated via the first and second methods are quite different. They are 44% and 24%, respectively.
- the first order polynomial fit in the second method can be replaced with other orders of polynomial fit, such as the 2nd order, the 3rd order, etc., or can also be replaced with combinations of orders of polynomial fit.
- the fit does not have to use all data points; instead, it can be among selected data points, such as the first several data points and/or the last several data points.
- FIG. 6 presents another exemplary process flow for determining a hemodynamic parameter.
- the process flow comprises receiving a first portion of data associated with at least one heart beat.
- the process flow comprises interpolating a second portion of the data based on the first portion of the data.
- the process flow comprises calculating at least one standard deviation for at least one of the first portion of the data or the second portion of the data.
- the process flow comprises determining the hemodynamic parameter based on the at least one standard deviation.
- Each step of any process flow described herein may be performed by a single computing device processor or different computing device processors.
- some of the steps may be performed by a single computing device processor, while other steps may be performed by individual computing device processors. Similar to FIG. 5 , the process flow in FIG. 6 may be applicable to any hemodynamic parameter, including, but not limited to SVV, SPV, PPV, and PVI.
- FIG. 7 shows a system that may be used to determine any hemodynamic parameter, including, but not limited to SVV, SPV, PPV, and PVI.
- FIG. 7 shows two types of pressure sensing for the sake of conciseness; in most practical applications of the disclosure, either one or several variations will typically be implemented.
- a conventional pressure sensor 7100 e.g., a disposable pressure transducer
- a catheter 7110 which is inserted in an artery 7120 of a portion 7130 of the body of a human or animal patient.
- Such an artery could be an ascending aorta, or pulmonary artery, or, in order to reduce the level of invasiveness, the artery 7120 could be peripheral, such as the femoral, radial or brachial artery.
- a conventional pressure sensor 7200 such as a photo-plethysmographic blood pressure probe, is mounted externally in any conventional manner, for example using a cuff around a finger 7230 or a transducer mounted on the wrist of the patient.
- the sensor 7100 or 7200 may comprise a pressure transducer (e.g., a disposable pressure transducer DPT).
- FIG. 7 schematically shows both types.
- the signals from the sensors 7100 , 7200 are passed via any known connectors as inputs to a processing system 7300 , which includes one or more processors and other supporting hardware and system software (not shown) usually included to process signals and execute code.
- the disclosure may be implemented using a modified, standard, personal computer, or it may be incorporated into a larger, specialized monitoring system.
- the processing system 7300 also may include, or is connected to, conditioning circuitry 7302 which performs such normal signal processing tasks as amplification, filtering, ranging, etc., as needed, as well as optional high pass filtering.
- the conditioned, sensed input pressure signal P(t) is then converted to digital form by a conventional analog-to-digital converter ADC 7304 , which has or takes its time reference from a clock circuit 7305 .
- ADC 7304 the sampling frequency of the ADC 7304 should be chosen with regard to the Nyquist criterion so as to avoid aliasing of the pressure signal.
- the output from the ADC 7304 will be the discrete pressure signal P(k), whose values may be stored in conventional memory circuitry (not shown).
- the values P(k) are passed to (usually, accessed from memory by) to a software module 7310 comprising computer-executable code for computing whichever of the parameters are to be used in the chosen algorithm for calculating the K.
- the patient-specific data such as age, height, weight, body surface area, etc.
- a memory 7315 which may also store other predetermined parameters. These values may be entered using any known input device 7400 in the conventional manner.
- a compliance calculation module 7320 also comprising computer-executable code, then takes as inputs the various moment and patient-specific values and performs the chosen calculations for computing the arterial compliance function K (or compliance factor C). For example, the module 7320 could enter the parameters into the expression given below for K (or C), or into some other expression derived by creating an approximating function that best fits a set of test data. The calculation module 7320 preferably also selects the time window over which each K, C, SV, CO, SVV, SPV, PPV, and/or PVI estimate is generated.
- a stroke volume computation module 7330 again comprising computer-executable code, then computes an SV estimate.
- a CO computation module 7330 may then generate an estimate of CO using the method described herein.
- Additional software modules 7360 and 7370 may be included to perform the calculations described above to estimate the exponential pressure decay constant tau and vascular resistance R.
- the vascular resistance R may also be referred to as the systemic vascular resistance.
- Still additional software modules may be included to determine or calculate any hemodynamic parameter described herein, including, but not limited to, SVV, PPV, SPV, or PVI.
- the software modules 7320 , 7330 , 7350 , 7360 , and 7370 may be implemented within an estimation software component 317 , which may of course be combined with the moment-calculating component 7310 , or with other software components of the processing system 7300 as desired.
- any or all of the results K, SV, CO, tau and R may be passed to any conventional display or recording device 7500 for presentation to and interpretation by a user or another system.
- the display 7500 will typically be the same as is used by the processing system for other purposes.
- the disclosure further relates to a computer program loadable in a computer unit or the processing system 7300 in order to execute the methods of the disclosure.
- the various software modules 7310 , 7315 , 7320 , 7330 , 7340 , 7350 , 7360 , and 7370 used to perform the various calculations and perform related method steps according to the disclosure may also be stored as computer-executable instructions on a computer-readable medium in order to allow the instructions to be loaded into and executed by different processing systems.
- module with respect to an apparatus may refer to a hardware component of the apparatus, a software component of the apparatus, or a component of the apparatus that includes both hardware and software.
- a module may include one or more modules, where each module may reside in separate pieces of hardware or software.
- an apparatus may alternatively be referred to as a “system” or a “device.”
- the present disclosure may include and/or be embodied as an apparatus (including, for example, a system, apparatus, machine, device, computer program product, and/or the like), as a method (including, for example, a business method, computer-implemented process, and/or the like), or as any combination of the foregoing.
- embodiments of the present disclosure may take the form of an entirely business method embodiment, an entirely software embodiment (including firmware, resident software, micro-code, stored procedures in a database, or the like), an entirely hardware embodiment, or an embodiment combining business method, software, and hardware aspects that may generally be referred to herein as a “system” or “apparatus.”
- embodiments of the present disclosure may take the form of a computer program product that includes a computer-readable storage medium having one or more computer-executable program code portions stored therein.
- a processor which may include one or more processors, may be “configured to” perform a certain function in a variety of ways, including, for example, by having one or more general-purpose circuits perform the function by executing one or more computer-executable program code portions embodied in a computer-readable medium, and/or by having one or more application-specific circuits perform the function.
- the computer-readable medium may include, but is not limited to, a non-transitory computer-readable medium, such as a tangible electronic, magnetic, optical, electromagnetic, infrared, and/or semiconductor system, device, and/or other apparatus.
- the non-transitory computer-readable medium includes a tangible medium such as a portable computer diskette, a hard disk, a random access memory (RAM), a read-only memory (ROM), an erasable programmable read-only memory (EPROM or Flash memory), a compact disc read-only memory (CD-ROM), and/or some other tangible optical and/or magnetic storage device.
- the computer-readable medium may be transitory, such as, for example, a propagation signal including computer-executable program code portions embodied therein.
- One or more computer-executable program code portions for carrying out operations of the present disclosure may include object-oriented, scripted, and/or unscripted programming languages, such as, for example, Java, Perl, Smalltalk, C++, SAS, SQL, Python, Objective C, JavaScript, and/or the like.
- the one or more computer-executable program code portions for carrying out operations of embodiments of the present disclosure are written in conventional procedural programming languages, such as the “C” programming languages and/or similar programming languages.
- the computer program code may alternatively or additionally be written in one or more multi-paradigm programming languages, such as, for example, F #.
- These one or more computer-executable program code portions may be provided to a processor of a general purpose computer, special purpose computer, and/or some other programmable data processing apparatus in order to produce a particular machine, such that the one or more computer-executable program code portions, which execute via the processor of the computer and/or other programmable data processing apparatus, create mechanisms for implementing the steps and/or functions represented by the flowchart(s) and/or block diagram block(s).
- the one or more computer-executable program code portions may be stored in a transitory and/or non-transitory computer-readable medium (e.g., a memory or the like) that can direct, instruct, and/or cause a computer and/or other programmable data processing apparatus to function in a particular manner, such that the computer-executable program code portions stored in the computer-readable medium produce an article of manufacture including instruction mechanisms which implement the steps and/or functions specified in the flowchart(s) and/or block diagram block(s).
- a transitory and/or non-transitory computer-readable medium e.g., a memory or the like
- the one or more computer-executable program code portions may also be loaded onto a computer and/or other programmable data processing apparatus to cause a series of operational steps to be performed on the computer and/or other programmable apparatus.
- this produces a computer-implemented process such that the one or more computer-executable program code portions which execute on the computer and/or other programmable apparatus provide operational steps to implement the steps specified in the flowchart(s) and/or the functions specified in the block diagram block(s).
- computer-implemented steps may be combined with, and/or replaced with, operator- and/or human-implemented steps in order to carry out an embodiment of the present disclosure.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Cardiology (AREA)
- General Health & Medical Sciences (AREA)
- Pathology (AREA)
- Physiology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Surgery (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Heart & Thoracic Surgery (AREA)
- Signal Processing (AREA)
- Hematology (AREA)
- Artificial Intelligence (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Psychiatry (AREA)
- Vascular Medicine (AREA)
- Data Mining & Analysis (AREA)
- Databases & Information Systems (AREA)
- Epidemiology (AREA)
- Primary Health Care (AREA)
- Pulmonology (AREA)
- Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
Abstract
Description
Claims (20)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US14/770,409 US10610166B2 (en) | 2013-07-08 | 2014-07-08 | Determination of a hemodynamic parameter |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361843722P | 2013-07-08 | 2013-07-08 | |
| PCT/US2014/045701 WO2015006295A1 (en) | 2013-07-08 | 2014-07-08 | Determination of a hemodynamic parameter |
| US14/770,409 US10610166B2 (en) | 2013-07-08 | 2014-07-08 | Determination of a hemodynamic parameter |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| US20160038097A1 US20160038097A1 (en) | 2016-02-11 |
| US10610166B2 true US10610166B2 (en) | 2020-04-07 |
Family
ID=52280511
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US14/770,409 Active 2037-02-15 US10610166B2 (en) | 2013-07-08 | 2014-07-08 | Determination of a hemodynamic parameter |
Country Status (3)
| Country | Link |
|---|---|
| US (1) | US10610166B2 (en) |
| EP (2) | EP3019075B1 (en) |
| WO (1) | WO2015006295A1 (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102015116655A1 (en) | 2015-10-01 | 2017-04-06 | Claas Selbstfahrende Erntemaschinen Gmbh | Harvester |
| GB2557199B (en) | 2016-11-30 | 2020-11-04 | Lidco Group Plc | Haemodynamic monitor with improved filtering |
| EP3342332B1 (en) * | 2016-12-28 | 2024-03-13 | Samsung Electronics Co., Ltd. | Adaptive bio-signal feature combining apparatus and method |
| EP3565461B1 (en) * | 2017-01-04 | 2023-03-29 | Koninklijke Philips N.V. | Device, system and method for determining pulse pressure variation of a subject |
| CN119112141B (en) * | 2024-11-15 | 2025-02-28 | 中国人民解放军总医院 | A method and device for monitoring hemodynamics of experimental animals |
Citations (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020062086A1 (en) | 2000-03-23 | 2002-05-23 | Miele Frank R. | Method and apparatus for assessing hemodynamic parameters within the circulatory system of a living subject |
| US20040077953A1 (en) | 2002-10-18 | 2004-04-22 | Turcott Robert G. | Hemodynamic analysis |
| US20050124904A1 (en) | 2003-12-05 | 2005-06-09 | Luchy Roteliuk | Arterial pressure-based, automatic determination of a cardiovascular parameter |
| US20080033305A1 (en) | 2006-07-13 | 2008-02-07 | Hatib Feras S | Method and apparatus for continuous assessment of a cardiovascular parameter using the arterial pulse pressure propagation time and waveform |
| US7422562B2 (en) * | 2003-12-05 | 2008-09-09 | Edwards Lifesciences | Real-time measurement of ventricular stroke volume variations by continuous arterial pulse contour analysis |
| US20090018422A1 (en) | 2007-06-12 | 2009-01-15 | Triage Wireless, Inc. | Vital sign monitor for cufflessly measuring blood pressure using a pulse transit time corrected for vascular index |
| KR100954817B1 (en) | 2009-03-13 | 2010-04-28 | (주)바이오센스크리에티브 | System and method for testing blood vessel's health and stress through signal analysis of pluse wave |
| US20110022323A1 (en) * | 2009-07-24 | 2011-01-27 | John Yundt-Pacheco | System and Method to Determine Sigma of a Clinical Diagnostic Process |
| US20110105858A1 (en) | 2009-10-30 | 2011-05-05 | Cho Yong K | Method and apparatus to monitor change in inspiratory effort using intrathoracic blood pressure waveform morphology |
| US20110319724A1 (en) | 2006-10-30 | 2011-12-29 | Cox Paul G | Methods and systems for non-invasive, internal hemorrhage detection |
| US20130053664A1 (en) * | 2010-01-29 | 2013-02-28 | Edwards Lifesciences Corporation | Elimination of the effects of irregular cardiac cycles in the determination of cardiovascular parameters |
| JP2013519410A (en) | 2010-02-11 | 2013-05-30 | リドコ グループ ピーエルシー | Hemodynamic monitor and method of hemodynamic monitor |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4236527A (en) | 1978-10-20 | 1980-12-02 | Massachusetts General Hospital | Cardiac output detection by multiple frequency thermodilution |
| US4507974A (en) | 1983-04-21 | 1985-04-02 | The Board Of Trustees Of The Leland Stanford Jr. University | Method and apparatus for measuring flow |
| US5146414A (en) | 1990-04-18 | 1992-09-08 | Interflo Medical, Inc. | Method and apparatus for continuously measuring volumetric flow |
| NL9100150A (en) | 1991-01-29 | 1992-08-17 | Tno | METHOD FOR DETERMINING THE BATTLE VOLUME AND THE HEART MINUTE VOLUME OF THE HUMAN HEART. |
| US5535753A (en) | 1994-10-04 | 1996-07-16 | Rutgers University | Apparatus and methods for the noninvasive measurement of cardiovascular system parameters |
| US5687733A (en) | 1995-10-26 | 1997-11-18 | Baxter International Inc. | System and method for estimating cardiac output |
| US7220230B2 (en) | 2003-12-05 | 2007-05-22 | Edwards Lifesciences Corporation | Pressure-based system and method for determining cardiac stroke volume |
| US20090048527A1 (en) | 2007-08-13 | 2009-02-19 | Edwards Lifesciences Corporation | Assessment of preload dependence and fluid responsiveness |
| WO2015006191A1 (en) | 2013-07-08 | 2015-01-15 | Edwards Lifesciences Corporation | Arterial pressure-based determination of cardiovascular parameters |
-
2014
- 2014-07-08 EP EP14822728.3A patent/EP3019075B1/en active Active
- 2014-07-08 EP EP16202415.2A patent/EP3170447A1/en not_active Withdrawn
- 2014-07-08 US US14/770,409 patent/US10610166B2/en active Active
- 2014-07-08 WO PCT/US2014/045701 patent/WO2015006295A1/en active Application Filing
Patent Citations (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020062086A1 (en) | 2000-03-23 | 2002-05-23 | Miele Frank R. | Method and apparatus for assessing hemodynamic parameters within the circulatory system of a living subject |
| US20040077953A1 (en) | 2002-10-18 | 2004-04-22 | Turcott Robert G. | Hemodynamic analysis |
| US20050124904A1 (en) | 2003-12-05 | 2005-06-09 | Luchy Roteliuk | Arterial pressure-based, automatic determination of a cardiovascular parameter |
| WO2005055825A1 (en) | 2003-12-05 | 2005-06-23 | Edwards Lifesciences Corporation | Arterial pressure-based, automatic determination of a cardiovascular parameter |
| US7422562B2 (en) * | 2003-12-05 | 2008-09-09 | Edwards Lifesciences | Real-time measurement of ventricular stroke volume variations by continuous arterial pulse contour analysis |
| US20080033305A1 (en) | 2006-07-13 | 2008-02-07 | Hatib Feras S | Method and apparatus for continuous assessment of a cardiovascular parameter using the arterial pulse pressure propagation time and waveform |
| US20110319724A1 (en) | 2006-10-30 | 2011-12-29 | Cox Paul G | Methods and systems for non-invasive, internal hemorrhage detection |
| US20090018422A1 (en) | 2007-06-12 | 2009-01-15 | Triage Wireless, Inc. | Vital sign monitor for cufflessly measuring blood pressure using a pulse transit time corrected for vascular index |
| KR100954817B1 (en) | 2009-03-13 | 2010-04-28 | (주)바이오센스크리에티브 | System and method for testing blood vessel's health and stress through signal analysis of pluse wave |
| US20110022323A1 (en) * | 2009-07-24 | 2011-01-27 | John Yundt-Pacheco | System and Method to Determine Sigma of a Clinical Diagnostic Process |
| US20110105858A1 (en) | 2009-10-30 | 2011-05-05 | Cho Yong K | Method and apparatus to monitor change in inspiratory effort using intrathoracic blood pressure waveform morphology |
| US20130053664A1 (en) * | 2010-01-29 | 2013-02-28 | Edwards Lifesciences Corporation | Elimination of the effects of irregular cardiac cycles in the determination of cardiovascular parameters |
| JP2013519410A (en) | 2010-02-11 | 2013-05-30 | リドコ グループ ピーエルシー | Hemodynamic monitor and method of hemodynamic monitor |
Non-Patent Citations (4)
| Title |
|---|
| Extended European Search Report issued in Application No. EP16202415.2, completed Apr. 18, 2017. |
| Frazier J et al: "Getting ml/beat from mmHg Arterial Pressure-based Cardiac Output The Edwards Flortrac Algorithm", Internet Citation, Jan. 1, 2012, pp. 1-4; Retrieved from the internet: URL:http://www.edwards.com/products/mininvasive/Pages/flotracalgorithmpdf.aspx. |
| Int'l. Search Report for PCT/US2014/045701, dated Oct. 27, 2014. |
| Supplementary European Search Report issued in EP14822728, Completed Jan. 18, 2017. |
Also Published As
| Publication number | Publication date |
|---|---|
| US20160038097A1 (en) | 2016-02-11 |
| EP3019075A1 (en) | 2016-05-18 |
| EP3019075B1 (en) | 2020-03-25 |
| WO2015006295A1 (en) | 2015-01-15 |
| EP3019075A4 (en) | 2017-02-22 |
| EP3170447A1 (en) | 2017-05-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2528499B1 (en) | Elimination of the effects of irregular cardiac cycles in the determination of cardiovascular parameters | |
| CN100528073C (en) | Arterial pressure-based, automatic determination of a cardiovascular parameter | |
| CN101502414B (en) | Apparatus and method for determining a physiological parameter | |
| US20090048527A1 (en) | Assessment of preload dependence and fluid responsiveness | |
| US20090270739A1 (en) | Real-time detection of vascular conditions of a subject using arterial pressure waveform analysis | |
| US20100204591A1 (en) | Calculating Cardiovascular Parameters | |
| CA2548592A1 (en) | Arterial pressure-based, automatic determination of a cardiovascular parameter | |
| US20100204590A1 (en) | Detection of Vascular Conditions Using Arterial Pressure Waveform Data | |
| US10610166B2 (en) | Determination of a hemodynamic parameter | |
| WO2014153202A1 (en) | Apparatus and methods for computing cardiac output of a living subject via applanation tonometry | |
| EP3019076B1 (en) | Arterial pressure-based determination of cardiovascular parameters | |
| Vakily et al. | A system for continuous estimating and monitoring cardiac output via arterial waveform analysis | |
| CN102413760B (en) | Monitoring peripheral decoupling | |
| US9968304B2 (en) | Detecting a vasoactive agent in the bloodstream | |
| CN107427245A (en) | Blood circulation disorder measurement apparatus and its method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AS | Assignment |
Owner name: EDWARDS LIFESCIENCES CORPORATION, CALIFORNIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:JIAN, ZHONGPING;SETTELS, JACOBUS J.G.M.;HATIB, FERAS;SIGNING DATES FROM 20130723 TO 20130828;REEL/FRAME:036767/0142 |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: NOTICE OF ALLOWANCE MAILED -- APPLICATION RECEIVED IN OFFICE OF PUBLICATIONS |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: PUBLICATIONS -- ISSUE FEE PAYMENT RECEIVED |
|
| STCF | Information on status: patent grant |
Free format text: PATENTED CASE |
|
| MAFP | Maintenance fee payment |
Free format text: PAYMENT OF MAINTENANCE FEE, 4TH YEAR, LARGE ENTITY (ORIGINAL EVENT CODE: M1551); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY Year of fee payment: 4 |
|
| AS | Assignment |
Owner name: BD SWITZERLAND SARL, SWITZERLAND Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:EDWARDS LIFESCIENCES CORPORATION;EDWARDS LIFESCIENCES LLC;EDWARDS LIFESCIENCES SARL;AND OTHERS;REEL/FRAME:070634/0001 Effective date: 20240903 Owner name: BECTON, DICKINSON AND COMPANY, NEW JERSEY Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:BD SWITZERLAND SARL;REEL/FRAME:070179/0813 Effective date: 20241021 |